MW02

· Mabwell (Shanghai) Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MW02, covering 2022-03-28 to 2022-03-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD [Phase 2, Phase 3]